Deep Bio Inc.

Deep Bio Inc.

Private
SeoulHealthcare & Life Scienceshttps://deepbio.co.kr/

Last Round

Series B

Extension

Jun 5, 2020

Est. Valuation

$19.6M

Total Funding Raised

$17.14M

Momentum Score

50 /100

Company Overview

Deep Bio Inc. is a healthcare AI company that develops deep learning-based software to aid in cancer pathology diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Drug Discovery

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

computational pathologydigital pathologyAI cancer diagnosticspathology AIprostate cancer AISoftware as a Medical DeviceSaMDwhole-slide imagingmedical imaging AIbreast cancer AIpathology workflowGleason gradingAI drug discoverydigital slide viewer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deep Bio Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Deep Bio Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJun 5, 2020
Series BMar 11, 2020
Series AMar 2, 2018

Key People

Founding team and executive leadership

Sun Woo Kim

CEO Founder

Founding Team

정회창

Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 33% MoM.

  • May 3, 2025

    Monthly visitors grew 95% MoM, reaching 4.1K.

Deep Bio Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Deep Bio Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Deep Bio Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range15
Year Founded2015
Last FundingJun 5, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.